Guerbet SA
PAR:GBT

Watchlist Manager
Guerbet SA Logo
Guerbet SA
PAR:GBT
Watchlist
Price: 13.88 EUR 1.31% Market Closed
Market Cap: 175.4m EUR

Net Margin
Guerbet SA

1%
Current
0.1%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1%
=
Net Income
7.7m
/
Revenue
809.7m

Net Margin Across Competitors

No Stocks Found

Guerbet SA
Glance View

Market Cap
174.9m EUR
Industry
Health Care

Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France and currently employs 2,730 full-time employees. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

GBT Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1%
=
Net Income
7.7m
/
Revenue
809.7m
What is the Net Margin of Guerbet SA?

Based on Guerbet SA's most recent financial statements, the company has Net Margin of 1%.

Back to Top